Poznań University of Physical Education
Poznan, 61-871, Poland
NCT Number: NCT06891820
This study aims to analyze in detail selected indicators of appetite regulation, metabolism, and iron balance in competitive rowers undergoing intense exercise. The project involves assessing dynamic hormonal and biochemical changes in the athletes' bodies, which will allow a better understanding of the body's adaptive mechanisms to prolonged physical strain.
Research group: the research will be conducted in a homogeneous group of professional rowers (N=30), all competitors qualified for the Polish Youth Rowing Team:
* aged 19 - 24, because the age group must be homogeneous, * the size of the group is about thirty people, which in the case of a homogeneous group will enable statistical analyzes to be conducted.
Rowing performance test: At the beginning and end of the training camp, participants will perform a test on a rowing ergometer (Concept II, USA). Each subject will have to cover a distance of 2000 m in the shortest possible time, which is the distance starting in rowing competitions. The results of both tests will be considered in the selection for the championship team; therefore, athletes will be well motivated to perform both tests with maximum effort.
Blood samples will be taken from the cubital vein at three-time points: before each ergometer test (after overnight fasting), directly after the test, and after a 1-hour recovery period.
Looking for future studies?
Notify Me19 year–24 year
All sexes
Observational
Poznan, 61-871, Poland
The study aims to conduct a detailed analysis of selected indicators of appetite regulation, metabolism, inflammation, and iron balance in competitive rowers undergoing intense exercise. The project involves assessing dynamic hormonal and biochemical changes in the athletes' bodies, which will allow for a better understanding of the body's adaptive mechanisms to prolonged physical strain.
Research group: The research will be conducted in a homogeneous group of professional rowers (N=30), all competitors qualified for the Polish Youth. Rowing Team:
Rowing performance test: at the beginning and at the end of the training camp, participants will perform a test on a rowing ergometer (Concept II, USA), each subject will have to cover a distance of 2000 m in the shortest possible time, which is the distance starting in rowing competitions. The results of both tests will be considered in the selection for the championship team; therefore, athletes will be well motivated to perform both tests with maximum effort.
Blood samples will be taken from the cubital vein at three-time points: before each ergometer test (after overnight fasting), directly after the test, and after a 1-hour recovery period.
Measurement: All determined parameters will be measured with the available equipment in the biochemical laboratory of Poznan University of Physical Education, Faculty of Sport Sciences in Gorzow Wlkp., using commercial assay kits. Measurements will be performed by the project contractors.
(a) complete blood count (18 parameters) determined on the MYTHIC 18 hematology analyzer (Orphee Medical, Geneva, Switzerland). White blood cell indices: WBC (white blood cells), LYM (lymphocytes as a percentage), LYM (lymphocytes), MON (monocytes as a percentage), MON (monocytes), GRA (granulocytes as a percentage), GRA (granulocytes). Red blood cell indices: RBC (Red Blood Cells), HGB (Hemoglobin), HCT (Hematocrit), MCV (Mean Corpuscular Volume), MCH (Mean Corpuscular Hemoglobin), MCHC (Mean Corpuscular Hemoglobin Concentration), RDW (Red Blood cells Distribution Width). Platelet indices: PLT (Platelet), MPV (Mean Platelet Volume), PDW (Platelet Distribution Width), PCT (Thrombocrit) (b) gene expression.
Stress and recovery hormones:
Neurotransmitters associated with fatigue resistance:
Sex hormones and metabolic balance:
The iron and Total Iron Binding Capacity (TIBC) levels will be determined using the colorimetric method on the SPECTROstar Nano reader. Unsaturated Iron Binding Capacity (UIBC) will be calculated from the formula: UIBC = TIBC-iron in serum)
Markers of muscle damage:
Markers of metabolic adaptation and recovery:
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
The examined athletes will be subjected to an effort on a rowing ergometer, covering a designated distance in the shortest possible time.
Time frame: At rest (before the test), directly after the test, and after a 1-hour recovery period.
Using MYTHIC18 hematology analyzer (Cormay Diagnostics, Geneva, Switzerland). Qualitative and quantitative evaluation of morphological elements of blood (determination in venous blood).
Time frame: At rest (before the test), directly after the test, and after a 1-hour recovery period.
Concentration of glycogen [ng/mL]. Immunoenzymatic assay method using a diagnostic ELISA Kit
Time frame: At rest (before the test), directly after the test, and after a 1-hour recovery period.
Concentration of insulin [μIU/mL]. Immunoenzymatic assay method using a diagnostic ELISA Kit
Time frame: At rest (before the test), directly after the test, and after a 1-hour recovery period.
Concetration of CK [ng/ml]. Immunoenzymatic assay method using a diagnostic ELISA Kit
Time frame: At rest (before the test), directly after the test, and after a 1-hour recovery period.
Concentration of Il-6 [pg/mL]. Immunoenzymatic assay method using a diagnostic ELISA Kit
Time frame: At rest (before the test), directly after the test, and after a 1-hour recovery period.
Concentration of FGF-21 [pg/mL]. Immunoenzymatic assay method using a diagnostic ELISA Kit
Time frame: At rest (before the test), directly after the test, and after a 1-hour recovery period.
Concetration of LA [mmol/l]. Using a portable biochemical photometer Vario Photometer II (Diaglobal, Berlin, Germany) (capillary blood from the ear lobe).
Time frame: At rest (before the test), directly after the test, and after a 1-hour recovery period.
Genes studied: LEP, GHRL, AGRP, GOT1 and GPX4.
RNA isolation will be performed by the column method on the Direct-zol™ RNA MiniPrep Plus Kits, according to the test manufacturer's instructions. Gene expression analysis from cells isolated from blood will be performed by reverse transcription using TaqMan
Time frame: At rest (before the test), directly after the test, and after a 1-hour recovery period.
Concentration of testosterone [ng/mL]. Immunoenzymatic assay method using a diagnostic ELISA Kit
Time frame: At rest (before the exercise test), 1 minute after the end of the test, after 1 hour of recovery
Concentration of serotonin [ng/mL]. Immunoenzymatic assay method using a diagnostic ELISA Kit
Time frame: At rest (before the exercise test), 1 minute after the end of the test, after 1 hour of recovery
Concentration of progesterone [ng/mL]. Immunoenzymatic assay method using a diagnostic ELISA Kit
Time frame: At rest (before the exercise test), 1 minute after the end of the test, after 1 hour of recovery
Concentration of estradiol [ng/mL]. Immunoenzymatic assay method using a diagnostic ELISA Kit
Time frame: At rest (before the exercise test), 1 minute after the end of the test, after 1 hour of recovery
Concentration of dopamine [ng/mL]. Immunoenzymatic assay method using a diagnostic ELISA Kit
Time frame: At rest (before the exercise test).
The Profile of Mood States (POMS) questionnaire measures mood states and emotional well-being.
Time frame: At rest (before the exercise test).
Scale of Mental Toughness in Sport (SMTQ) - to assess an athlete's ability to cope with training loads and stress
Time frame: At rest (before the exercise test).
The Eating Disorder Examination Questionnaire (EDE-Q) measures the severity of eating disorder behaviors and attitudes.
Time frame: At rest (before the exercise test).
The Visual Analogue Scale (VAS) measures subjective appetite sensations-linear scale from one to 10 where 10 is the strongest feeling.
Time frame: At rest (before the test), directly after the test, and after a 1-hour recovery period.
Satiety regulation marker. Concentration of leptin [pg/ml].ELISA method by the test manufacturer's instructions.
Time frame: At rest (before the test), directly after the test, and after a 1-hour recovery period.
Satiety regulation marker. Concentration of GLP-1 [pg/ml]. ELISA method by the test manufacturer's instructions.
Time frame: At rest (before the test), directly after the test, and after a 1-hour recovery period.
Satiety regulation marker. Concentration of leptin [pg/ml]. ELISA method by the test manufacturer's instructions.
Time frame: At rest (before the test), directly after the test, and after a 1-hour recovery period.
Satiety regulation marker. Concentration of PP [pg/ml]. ELISA method by the test manufacturer's instructions
Time frame: At rest (before the test), directly after the test, and after a 1-hour recovery period.
Hunger regulation marker. Concentration of GHRL [pg/ml].ELISA method by the test manufacturer's instructions.
Time frame: At rest (before the test), directly after the test, and after a 1-hour recovery period.
Satiety regulation marker. Concentration of CCK [pg/ml].ELISA method by the test manufacturer's instructions.
Time frame: At rest (before the test), directly after the test, and after a 1-hour recovery period.
Concentration of Soluble transferrin receptor [μg/ml]. ELISA method by the test manufacturer's instructions.
Time frame: At rest (before the test), directly after the test, and after a 1-hour recovery period.
Concentration of ferritin [ng/mL]. ELISA method by the test manufacturer's instructions
Time frame: At rest (before the test), directly after the test, and after a 1-hour recovery period.
Concentration of 4-Hydroxynonenal (4-HNE) [pg/ml]. ELISA method by the test manufacturer's instructions
Time frame: At rest (before the test), directly after the test, and after a 1-hour recovery period.
Concentration of Human Glutathione Peroxidase 4 (GPX4) [ng/mL]. ELISA method by the test manufacturer's instructions
Time frame: At rest (before the test), directly after the test, and after a 1-hour recovery period.
Concentration of Glutathione (GSH) [μg/mL]. ELISA method by the test manufacturer's instructions.
Time frame: At rest (before the test), directly after the test, and after a 1-hour recovery period.
Concentration of Heme Oxygenase 1 (HO-1) [ng/mL]. ELISA method by the test manufacturer's instructions
Time frame: At rest (before the test), directly after the test, and after a 1-hour recovery period.
Concentration of erythroferrone [ng/mL]. ELISA method by the test manufacturer's instructions
Time frame: At rest (before the test), directly after the test, and after a 1-hour recovery period.
Concentration of lactoferrin [ng/mL]. ELISA method by the test manufacturer's instructions
Time frame: At rest (before the test), directly after the test, and after a 1-hour recovery period.
The iron level [µg/dL] will be determined using the colorimetric method on the SPECTROstar Nano reader.
Time frame: At rest (before the test), directly after the test, and after a 1-hour recovery period.
Concentration of BUN [ml/dl]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe).
Time frame: At rest (before the test), directly after the test, and after a 1-hour recovery period.
Concentration of AGAP [mmol/l]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe).
Time frame: At rest (before the test), directly after the test, and after a 1-hour recovery period.
Concentration of Be ecf [mmol/l]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe).
Time frame: At rest (before the test), directly after the test, and after a 1-hour recovery period.
Concentration of Na [mmol/l]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe).
Time frame: At rest (before the test), directly after the test, and after a 1-hour recovery period.
Concentration of Ca [mmol/l]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe).
Time frame: At rest (before the test), directly after the test, and after a 1-hour recovery period.
Concentration of K [mmol/l]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe).
Time frame: At rest (before the test), directly after the test, and after a 1-hour recovery period.
Concentration of Cl [mmol/l]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe).
Time frame: At rest (before the test), directly after the test, and after a 1-hour recovery period.
Concentration of cHCO3 [mmol/l]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe).
Time frame: At rest (before the test), directly after the test, and after a 1-hour recovery period.
Concentration of tCO2 [mmol/l]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe).
Time frame: At rest (before the test), directly after the test, and after a 1-hour recovery period.
Concentration of pCO2 [mmol/l]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe).
Time frame: At rest (before the test), directly after the test, and after a 1-hour recovery period.
Concentration of pO2 [mmol/l]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe).
Time frame: At rest (before the test), directly after the test, and after a 1-hour recovery period.
Concentration of cSO2 [mmol/l]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe).
Time frame: At rest (before the test), directly after the test, and after a 1-hour recovery period.
Concentration of urea [mmol/l]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe).
Time frame: At rest (before the test), directly after the test, and after a 1-hour recovery period.
Concentration of crea [mg/dl]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe).
Time frame: At rest (before the test), directly after the test, and after a 1-hour recovery period.
Concentration of hct [%]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe).
Time frame: At rest (before the test), directly after the test, and after a 1-hour recovery period.
Concentration of chgb [mmol/l]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe).
Time frame: At rest (before the test), directly after the test, and after a 1-hour recovery period.
Concentration of glu [mg/dl]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe).
Time frame: Day 1 after overall fast
Prior to the exercise test, we measured the anthropometric parameters, including height (Seca 213 Hamburg, Deutschland) [cm]
Time frame: Day 1 after overall fast
Prior to the exercise test, we measured the anthropometric parameters, including weight (Tanita BC 418 MA, Tanita Corporation, Tokyo, Japan) [kg]
Time frame: Day 1 after overall fast
Prior to the exercise test, we measured the anthropometric parameters, including lean body mas (Tanita BC 418 MA, Tanita Corporation, Tokyo, Japan) [kg]
Time frame: Day 1 after overall fast
Prior to the exercise test, we measured the anthropometric parameters, including total body water (Tanita BC 418 MA, Tanita Corporation, Tokyo, Japan) [kg]
Time frame: Day 1 after overall fast
Prior to the exercise test, we measured the anthropometric parameters, including water (Tanita BC 418 MA, Tanita Corporation, Tokyo, Japan) [%]
Time frame: Day 1 after overall fast
Prior to the exercise test, we measured the anthropometric parameters, including fat (Tanita BC 418 MA, Tanita Corporation, Tokyo, Japan) [%]
Time frame: Day before the Day 1, in the morning at Day 1
Participants will prepare a food record. The results will be calculated using the dietetykpro program: energy [kcal]
Time frame: Day before the Day 1, in the morning at Day 1
Participants will prepare a food record. The results will be calculated using the dietetykpro program: protein [g]
Time frame: Day before the Day 1, in the morning at Day 1
Participants will prepare a food record. The results will be calculated using the dietetykpro program: carbohydrates [g]
Time frame: Day before the Day 1, in the morning at Day 1
Participants will prepare a food record. The results will be calculated using the dietetykpro program: fiber [g]
Time frame: Day before the Day 1, in the morning at Day 1
Participants will prepare a food record. The results will be calculated using the dietetykpro program: fat [g]
Poznan University of Physical Education
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06863116
Ferroptosis, Hypoxia
Izmir, Turkey (Türkiye)
View Trial DetailsNCT07722637
Arterial Occlusive Diseases, Arteriosclerosis
Kayseri, Turkey (Türkiye)
View Trial DetailsNCT05924074
Bone Marrow Diseases, Ferroptosis
Pessac, France
View Trial DetailsNCT07726979
Athletic Performance, Bone Metabolism
Surabaya, Jawa Timur - East Java, Indonesia
View Trial Details